- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advanced Malignant Cancer in United Kingdom
Total 26942 results
-
Eisai Inc.Completed
-
Mast Therapeutics, Inc.CompletedAdvanced CancerUnited States, Argentina, Estonia
-
OHSU Knight Cancer InstituteNational Cancer Institute (NCI); Oregon Health and Science UniversityRecruitingAdvanced Malignant Solid NeoplasmUnited States
-
Eisai LimitedCompletedOvarian Cancer | Triple Negative Breast Cancer | Malignant Solid Tumour | Advanced Melanoma | B-cell Malignancy, Low-gradeUnited Kingdom
-
King's College LondonPrincess Alice HospiceCompleted
-
Liverpool University Hospitals NHS Foundation TrustUniversity of LiverpoolCompleted
-
Eli Lilly and CompanyCompletedColorectal Cancer | Mantle Cell Lymphoma | Advanced CancerUnited States, France, United Kingdom
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Belgium, Spain, Argentina, Japan, Korea, Republic of
-
M.D. Anderson Cancer CenterPfizerCompleted
-
M.D. Anderson Cancer CenterTerminated
-
M.D. Anderson Cancer CenterNational Center for Research Resources (NCRR)UnknownAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterNational Center for Research Resources (NCRR)UnknownAdvanced CancersUnited States
-
Vanderbilt-Ingram Cancer CenterHuman Animal Bond Research InstituteCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Novartis PharmaceuticalsCompletedOestrogen Receptor Positive Advanced Breast CancerUnited Kingdom
-
ETOP IBCSG Partners FoundationHoffmann-La RocheActive, not recruitingPleural Mesothelioma Malignant AdvancedSwitzerland, United Kingdom, Belgium, Spain, France, Italy
-
AstraZenecaParexelCompletedAdvanced MalignanciesUnited Kingdom, United States
-
M.D. Anderson Cancer CenterMillennium Pharmaceuticals, Inc.CompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterCompletedAdvanced CancersUnited States
-
M.D. Anderson Cancer CenterCompleted
-
M.D. Anderson Cancer CenterCelgene CorporationCompleted
-
M.D. Anderson Cancer CenterEuropean CommissionCompletedAdvanced CancersUnited States, Spain, France, Israel
-
Bristol-Myers SquibbExelixisTerminatedMetastatic Cancer | Advanced Solid CancersUnited States, Canada, France
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerItaly, Australia, United States, Spain, Romania, Argentina, Canada, Chile, Finland, Germany, Poland
-
OHSU Knight Cancer InstituteNovartis Pharmaceuticals; Oregon Health and Science UniversityCompletedStage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Locally Advanced Leiomyosarcoma | Unresectable Leiomyosarcoma | Myxofibrosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Unresectable... and other conditionsUnited States
-
Yale UniversityCelgene CorporationTerminatedAdvanced Solid CancersUnited States
-
University Hospital Birmingham NHS Foundation TrustNot yet recruitingMalignancyUnited Kingdom
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCL Cancer Stage IIIB IVUnited Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMalignant Hepatobiliary NeoplasmUnited States
-
Heidelberg Pharma AGTerminatedAdvanced Solid TumoursUnited Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
RS Oncology LLCRecruitingMesothelioma | Malignant Pleural Mesothelioma | Pleural Effusion, Malignant | Mesotheliomas Pleural | Malignant Pleural Effusion | Mesothelioma; LungUnited Kingdom
-
Yale UniversityAgennixCompletedAdvanced CancersUnited States
-
Piramal Enterprises LimitedMelanoma Research Foundation Breakthrough ConsortiumSuspendedAdvanced or Inoperable Malignant Melanoma With BRAF MutationUnited States
-
Nektar TherapeuticsCompletedAdvanced Cancer | Metastatic Solid TumorsUnited States
-
AstraZenecaActive, not recruitingER+ HER2- Advanced Breast CancerUnited States, Spain, United Kingdom
-
Mayo ClinicNational Cancer Institute (NCI)WithdrawnHematopoietic and Lymphoid Cell Neoplasm | Advanced Malignant Solid NeoplasmUnited States
-
Bristol-Myers SquibbTerminatedAdvanced CancerChile, United States, Argentina, Australia, Belgium, Canada, Finland, France, Germany, Israel, Italy, Netherlands, Norway, Poland, Romania, Spain, Switzerland
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Terminated
-
Eli Lilly and CompanyCompletedAdvanced CancerPuerto Rico, United States
-
AstraZenecaCompletedAdvanced or Metastatic Breast Cancer | ER+ve Advanced or Metastatic Breast CancerCanada, France, Korea, Republic of, Czechia, Peru, United Kingdom, Spain, Japan, Mexico, Singapore, Bulgaria
-
Sequana Medical N.V.CompletedMalignant AscitesGermany, Switzerland, United Kingdom
-
Eli Lilly and CompanyTerminatedLymphoma | Advanced CancerUnited Kingdom
-
M.D. Anderson Cancer CenterCompletedAdvanced Cancer | Liver CancerUnited States
-
M.D. Anderson Cancer CenterGlaxoSmithKline; National Comprehensive Cancer NetworkCompletedSolid Tumors | Advanced CancersUnited States
-
University of California, San FranciscoMerck Sharp & Dohme LLCCompletedCancer | Advanced Solid Tumors | TumorsUnited States
-
TaiRx, Inc.CompletedCarcinoma | Advanced CancerUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingAdvanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Multiple MyelomaUnited States